FC
VIR icon

FORA Capital’s Vir Biotechnology VIR Stock Holding History

FORA Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,732
Closed -$69.5K – 713
2025
Q1 		$69.5K Buy
+10,732
New +$95.4K 0.01% 470
2021
Q3 		– Sell
-2,806
Closed -$133K – 863
2021
Q2 		$133K Buy
+2,806
New +$128K 0.02% 531
2021
Q1 		– Sell
-565
Closed -$15K – 1130
2020
Q4 		$15K Buy
+565
New +$18.4K ﹤0.01% 890
2020
Q3 		– Sell
-11,268
Closed -$462K – 1007
2020
Q2 		$462K Buy
+11,268
New +$378K 0.16% 169

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FORA Capital's VIR Position: Q2 2025 in Review

FORA Capital sold out of Vir Biotechnology (VIR) in Q2 2025, closing a stake of 10,732 shares — an estimated $69.5K sold.

FORA Capital first reported a position in VIR in Q2 2020 and held it in 4 quarters. The position peaked at $462K in Q2 2020. 213 funds tracked by Wall St. Rank hold VIR as of Q2 2025.

  • FORA Capital reported no remaining Vir Biotechnology position as of Q2 2025 after selling out during the quarter.
  • FORA Capital sold 10,732 Vir Biotechnology shares in Q2 2025, an estimated $69.5K.
  • FORA Capital first reported a position in Vir Biotechnology in Q2 2020 and held it in 4 quarters.
  • FORA Capital's Vir Biotechnology position peaked at $462K in Q2 2020.
  • 213 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2025.

Based on FORA Capital's 13F filing for Q2 2025, filed 13 Aug 2025.